Century Therapeutics, Inc. (IPSC) vs ARS Pharmaceuticals, Inc. (SPRY)
- Century Therapeutics, Inc. IPSC 1.68 +11.26%
- ARS Pharmaceuticals, Inc. SPRY 2.79 +5.28%
Century Therapeutics, Inc. and ARS Pharmaceuticals, Inc. are both Biotechnology companies. Century Therapeutics, Inc. and ARS Pharmaceuticals, Inc. are of similar size ($273.4M and $263.5M). Century Therapeutics, Inc. grew revenue faster over the last twelve months: 8,286.7% against −14.5%. Across the 14 metrics below, Century Therapeutics, Inc. leads on 9 and ARS Pharmaceuticals, Inc. on 5.
Valuation
Profitability
| Metric | IPSC | SPRY | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 0.00% | 68.51% |
| Operating margin | 0.00% | (161.50%) | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | (149.89%) | 0.00% |
| Return on equity | (49.65%) | 0.00% | (51.96%) |
| Return on assets | (38.41%) | 0.00% | (46.06%) |
| Return on invested capital | (64.92%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack